Alana B. McNulty
CIK 1606086 · Chief Business Officer · last filed 2025-06-13
Alana B. McNulty is a Chief Business Officer who has filed 8 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for JANX, was dated Jun 13, 2025. Current disclosed insider exposure totals $84.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$84.8K
2
8
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| JANX | Director | 6,250 | $13.56 | $84.8K | $0 | 5 | 2025-06-13 |
| eFFECTOR Therapeutics, Inc. (EFTRW) Delisted | Chief Business Officer | 48,768 | $0.00 | $29 | $0 | 3 | 2022-06-22 |
Recent Filings
8 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-13 | JANX | Grant (A) | +3,750 | $0 | EDGAR |
| 2024-06-28 | JANX | Grant (A) | +2,500 | $0 | EDGAR |
| 2023-06-16 | JANX | Grant (A) | — | $0 | EDGAR |
| 2022-06-22 | eFFECTOR Therapeutics, Inc. (EFTRW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-16 | JANX | Grant (A) | — | $0 | EDGAR |
| 2022-01-24 | eFFECTOR Therapeutics, Inc. (EFTRW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-09-09 | JANX | Grant (A) | — | $0 | EDGAR |
| 2021-08-27 | eFFECTOR Therapeutics, Inc. (EFTRW) Delisted | Grant (A) | +48,768 | $0 | EDGAR |